A nurse is reviewing the medical record of a client who has been on levothyroxine for several months.
Which of the following findings indicates a therapeutic response to the medication?

This question assesses understanding of the feedback loop in thyroid function. It requires applying knowledge of the hypothalamus-pituitary-thyroid axis, specifically how exogenous levothyroxine affects pituitary secretion of TSH, which is the primary indicator of thyroid replacement therapy effectiveness in hypothyroid patients.

Choice A rationale

Levothyroxine is a synthetic form of thyroxine (T4). If the medication is effective, T4 levels should increase or normalize to the standard range of 5.0 to 12.0 mcg/dL, rather than decrease, indicating that the patient has successfully corrected their hormone deficiency.

Choice B rationale

Increased sleep is not a specific indicator of a therapeutic response to levothyroxine. In fact, patients who are over-replaced may experience insomnia. Hypothyroid patients often report excessive lethargy, so normalization of energy levels, rather than increased sleep, is the desired outcome.

Choice C rationale

In a healthy feedback loop, TSH, with a normal range of 0.4 to 4.0 mIU/L, is suppressed by circulating T4. A decrease in TSH levels indicates that the exogenously administered levothyroxine is successfully restoring thyroid function to the patient's normal physiological range.

Choice D rationale

Weight gain is a classic symptom of hypothyroidism due to a slowed basal metabolic rate. A therapeutic response to levothyroxine should lead to weight normalization or loss as the patient's metabolism returns to its normal state, making an increase in weight undesirable.